Tekla Capital Management’s Edgewise Therapeutics EWTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | $1.17M | Sell |
150,418
-44,607
| -23% | -$346K | 0.05% | 127 |
|
|
2023
Q1 | $1.3M | Hold |
195,025
| – | – | 0.05% | 132 |
|
|
2022
Q4 | $1.74M | Hold |
195,025
| – | – | 0.07% | 118 |
|
|
2022
Q3 | $1.92M | Buy |
195,025
+134,475
| +222% | +$1.32M | 0.08% | 114 |
|
|
2022
Q2 | $482K | Hold |
60,550
| – | – | 0.02% | 153 |
|
|
2022
Q1 | $587K | Hold |
60,550
| – | – | 0.02% | 156 |
|
|
2021
Q4 | $925K | Buy |
+60,550
| New | +$925K | 0.03% | 147 |
|